发明名称 Therapeutically useful synthetic oligonucleotides
摘要 The present invention provides a composition and method comprising a 2-20 base 3'-OH, 5'-OH synthetic oligonucleotide (sequence) selected from the group consisting of (G<SUB>x</SUB>T<SUB>y</SUB>)<SUB>n</SUB>, (T<SUB>y</SUB>G<SUB>x</SUB>)<SUB>n</SUB>, a(G<SUB>x</SUB>T<SUB>y</SUB>)<SUB>n</SUB>, a(T<SUB>y</SUB>G<SUB>x</SUB>)<SUB>n</SUB>, (G<SUB>x</SUB>T<SUB>y</SUB>)<SUB>n</SUB>b, (T<SUB>y</SUB>G<SUB>x</SUB>)<SUB>n</SUB>b, a(G<SUB>x</SUB>T<SUB>y</SUB>)<SUB>n</SUB>b, a(T<SUB>y</SUB>G<SUB>x</SUB>)<SUB>n</SUB>b, wherein x and y is an integer between 1 and 7, n is an integer between 1 and 12, a and b are one or more As, Cs, Gs or Ts and wherein the sequence induces a response selected from the group consisting of induction of cell cycle arrest, inhibition of proliferation, activation of caspases and induction of apoptosis in cancer cells and production of cytokines by immune system cells.
申请公布号 US7157436(B2) 申请公布日期 2007.01.02
申请号 US20000735363 申请日期 2000.12.12
申请人 BIONICHE LIFE SCIENCES, INC. 发明人 PHILLIPS NIGEL C.;FILION MARIO C.
分类号 A01N43/04;A61K48/00;A01N61/00;A61K31/00;A61K31/138;A61K31/513;A61K31/7084;A61K31/7088;A61K31/7125;A61K38/00;A61K45/00;A61K45/06;A61K49/00;A61P7/00;A61P29/00;A61P31/00;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/04;A61P43/00;C07H21/04;C12N15/117;C12N15/63 主分类号 A01N43/04
代理机构 代理人
主权项
地址